دورية أكاديمية

Effects of Moderate Hepatic Impairment on the Pharmacokinetic Properties and Tolerability of Umeclidinium and Vilanterol in Inhalational Umeclidinium Monotherapy and Umeclidinium/Vilanterol Combination Therapy: An Open-Label, Nonrandomized Study

التفاصيل البيبلوغرافية
العنوان: Effects of Moderate Hepatic Impairment on the Pharmacokinetic Properties and Tolerability of Umeclidinium and Vilanterol in Inhalational Umeclidinium Monotherapy and Umeclidinium/Vilanterol Combination Therapy: An Open-Label, Nonrandomized Study
المؤلفون: Mehta, Rashmi, Hardes, Kelly, Kelleher, Dennis, Preece, Andrew, Tombs, Lee, Brealey, Noushin
المصدر: Clinical Therapeutics ; volume 36, issue 7, page 1016-1027.e2 ; ISSN 0149-2918
بيانات النشر: Elsevier BV
سنة النشر: 2014
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
مصطلحات موضوعية: Pharmacology (medical), Pharmacology
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.clinthera.2014.05.002
الإتاحة: https://doi.org/10.1016/j.clinthera.2014.05.002Test
https://api.elsevier.com/content/article/PII:S0149291814002513?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0149291814002513?httpAccept=text/plainTest
حقوق: https://www.elsevier.com/tdm/userlicense/1.0Test/
رقم الانضمام: edsbas.C7BF15D7
قاعدة البيانات: BASE